Trial Profile
A Phase 3 safety and efficacy study of etanercept in children with systemic onset juvenile rheumatoid arthritis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Prednisone
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 20 Feb 2008 Status changed from in progress to discontinued.
- 26 Oct 2005 New trial record.